Healthcare
FDA Approves Revolution Medicines Pancreatic Cancer Pill
The US FDA has approved Rasonque, a daily pill by Revolution Medicines that doubled survival rates in advanced pancreatic cancer clinical trials.
The US FDA has approved Rasonque, a daily pill by Revolution Medicines that doubled survival rates in advanced pancreatic cancer clinical trials.